Search

Simple Summary: Breast cancer is one of the most common health problems in the world. As a result, governments and researchers in different countries are trying to help prevent the disease. In this work, we develop a clinical decision support methodology based on machine learning tools. This methodology helps identify breast cancer patients and determine the risk factors for this disease. In addition, the proposed strategy can help detect the disease in its early stages using modern easy-to-interpret machine learning tools. Worldwide, the coronavirus has intensified the management problems of health services, significantly harming patients. Some of the most affected processes have been cancer patients' prevention, diagnosis, and treatment. Breast cancer is the most affected, with more than 20 million cases and at least 10 million deaths by 2020. Various studies have been carried out to support the management of this disease globally. This paper presents a decision support strategy for health teams based on machine learning (ML) tools and explainability algorithms (XAI). The main methodological contributions are: first, the evaluation of different ML algorithms that allow classifying patients with and without cancer from the available dataset; and second, an ML methodology mixed with an XAI algorithm, which makes it possible to predict the disease and interpret the variables and how they affect the health of patients. The results show that first, the XGBoost Algorithm has a better predictive capacity, with an accuracy of 0.813 for the train data and 0.81 for the test data; and second, with the SHAP algorithm, it is possible to know the relevant variables and their level of significance in the prediction, and to quantify the impact on the clinical condition of the patients, which will allow health teams to offer early and personalized alerts for each patient. [ABSTRACT FROM AUTHOR]

Portal hypertension is a complex medical condition characterized by elevated blood pressure in the portal venous system. The conventional diagnosis of such disease often involves invasive procedures such as liver biopsy, endoscopy, or imaging techniques with contrast agents, which can be uncomfortable for patients and carry inherent risks. This study presents a deep neural network method in support of the non-invasive diagnosis of portal hypertension in patients with chronic liver diseases. The proposed method utilizes readily available clinical data, thus eliminating the need for invasive procedures. A dataset composed of standard laboratory parameters is used to train and validate the deep neural network regressor. The experimental results exhibit reasonable performance in distinguishing patients with portal hypertension from healthy individuals. Such performances may be improved by using larger datasets of high quality. These findings suggest that deep neural networks can serve as useful auxiliary diagnostic tools, aiding healthcare professionals in making timely and accurate decisions for patients suspected of having portal hypertension. [ABSTRACT FROM AUTHOR]

Infertility is a social stigma for individuals, and male factors cause approximately 30% of infertility. Despite this, male infertility is underrecognized and underrepresented as a disease. According to the World Health Organization (WHO), changes in lifestyle and environmental factors are the prime reasons for the declining rate of male fertility. Artificial intelligence (AI)/machine learning (ML) models have become an effective solution for early fertility detection. Seven industry-standard ML models are used: support vector machine, random forest (RF), decision tree, logistic regression, naïve bayes, adaboost, and multi-layer perception to detect male fertility. Shapley additive explanations (SHAP) are vital tools that examine the feature's impact on each model's decision making. On these, we perform a comprehensive comparative study to identify good and poor classification models. While dealing with the all-above-mentioned models, the RF model achieves an optimal accuracy and area under curve (AUC) of 90.47% and 99.98%, respectively, by considering five-fold cross-validation (CV) with the balanced dataset. Furthermore, we provide the SHAP explanations of existing models that attain good and poor performance. The findings of this study show that decision making (based on ML models) with SHAP provides thorough explanations for detecting male fertility, as well as a reference for clinicians for further treatment planning. [ABSTRACT FROM AUTHOR]

Artificial intelligence and machine learning (AI/ML) research has aimed to achieve human-level performance in tasks that require understanding and decision making. Although major advances have been made, AI systems still struggle to achieve adaptive learning for generalization. One of the main approaches to generalization in ML is transfer learning, where previously learned knowledge is utilized to solve problems in a different, but related, domain. Another approach, pursued by cognitive scientists for several decades, has investigated the role of analogical reasoning in comparisons aimed at understanding human generalization ability. Analogical reasoning has yielded rich empirical findings and general theoretical principles underlying human analogical inference and generalization across distinctively different domains. Though seemingly similar, there are fundamental differences between the two approaches. To clarify differences and similarities, we review transfer learning algorithms, methods, and applications in comparison with work based on analogical inference. Transfer learning focuses on exploring feature spaces shared across domains through data vectorization while analogical inferences focus on identifying relational structure shared across domains via comparisons. Rather than treating these two learning approaches as synonymous or as independent and mutually irrelevant fields, a better understanding of how they are interconnected can guide a multidisciplinary synthesis of the two approaches. [ABSTRACT FROM AUTHOR]

The study was conducted by applying machine learning and data mining methods to treatment personalization. This allows individual patient characteristics to be investigated. The personalization method was built on the clustering method and associative rules. It was suggested to determine the average distance between instances in order to find the optimal performance metrics. The formalization of the medical data preprocessing stage was proposed in order to find personalized solutions based on current standards and pharmaceutical protocols. The patient data model was built using time-dependent and time-independent parameters. Personalized treatment is usually based on the decision tree method. This approach requires significant computation time and cannot be parallelized. Therefore, it was proposed to group people by conditions and to determine deviations of parameters from the normative parameters of the group, as well as the average parameters. The novelty of the paper is the new clustering method, which was built from an ensemble of cluster algorithms, and the usage of the new distance measure with Hopkins metrics, which were 0.13 less than for the k-means method. The Dunn index was 0.03 higher than for the BIRCH (balanced iterative reducing and clustering using hierarchies) algorithm. The next stage was the mining of associative rules provided separately for each cluster. This allows a personalized approach to treatment to be created for each patient based on long-term monitoring. The correctness level of the proposed medical decisions is 86%, which was approved by experts. [ABSTRACT FROM AUTHOR]